Dace Sondore

477 total citations
14 papers, 126 citations indexed

About

Dace Sondore is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dace Sondore has authored 14 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dace Sondore's work include Coronary Interventions and Diagnostics (9 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiac Valve Diseases and Treatments (3 papers). Dace Sondore is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiac Valve Diseases and Treatments (3 papers). Dace Sondore collaborates with scholars based in Latvia, Denmark and United Kingdom. Dace Sondore's co-authors include Andrejs Ērglis, Indulis Kumsārs, Sanda Jēgere, Michael Mæng, Inga Narbute, Pierfrancesco Agostoni, Jens Flensted Lassen, Luc Janssens, Stefan Verheye and Evald Høj Christiansen and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and JACC: Cardiovascular Interventions.

In The Last Decade

Dace Sondore

13 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dace Sondore Latvia 5 104 63 55 36 19 14 126
Hideo Matama Japan 5 80 0.8× 46 0.7× 57 1.0× 32 0.9× 5 0.3× 19 100
Florian Riede Switzerland 7 109 1.0× 82 1.3× 108 2.0× 34 0.9× 30 1.6× 13 174
K L Laugwitz Germany 4 133 1.3× 74 1.2× 138 2.5× 53 1.5× 37 1.9× 8 237
Youssef S. Abdelwahed Germany 8 110 1.1× 88 1.4× 81 1.5× 31 0.9× 7 0.4× 35 161
Ioannis Sarantitis United Kingdom 5 67 0.6× 27 0.4× 30 0.5× 14 0.4× 13 0.7× 8 134
Leng Han China 5 31 0.3× 19 0.3× 25 0.5× 13 0.4× 15 0.8× 9 67
Ruurt Jukema Netherlands 6 73 0.7× 113 1.8× 58 1.1× 23 0.6× 11 0.6× 39 198
P. Brown Australia 8 28 0.3× 46 0.7× 112 2.0× 13 0.4× 20 1.1× 26 169
Upul Wickramarachchi United Kingdom 8 159 1.5× 67 1.1× 130 2.4× 32 0.9× 5 0.3× 24 191
Juan Mieres Argentina 8 182 1.8× 78 1.2× 161 2.9× 38 1.1× 12 0.6× 30 207

Countries citing papers authored by Dace Sondore

Since Specialization
Citations

This map shows the geographic impact of Dace Sondore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dace Sondore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dace Sondore more than expected).

Fields of papers citing papers by Dace Sondore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dace Sondore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dace Sondore. The network helps show where Dace Sondore may publish in the future.

Co-authorship network of co-authors of Dace Sondore

This figure shows the co-authorship network connecting the top 25 collaborators of Dace Sondore. A scholar is included among the top collaborators of Dace Sondore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dace Sondore. Dace Sondore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Trušinskis, Kārlis, Sanda Jēgere, Inga Narbute, et al.. (2024). Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques. European Heart Journal. 45(Supplement_1). 1 indexed citations
2.
Trušinskis, Kārlis, Sanda Jēgere, Inga Narbute, et al.. (2024). PLAQUE LIPID CONTENT REDUCTION WITH BACKGROUND OF ATORVASTATIN VERSUS ROSUVASTATIN ESCALATED TO GENE-SILENCING THERAPY. Journal of the American College of Cardiology. 83(13). 1278–1278. 1 indexed citations
3.
Sondore, Dace, Kārlis Trušinskis, Inga Narbute, et al.. (2024). Bioresorbable Scaffold Use in Coronary Chronic Total Occlusions: A Long-Term, Single-Center Follow-Up Study. Medicina. 60(8). 1233–1233.
4.
Trušinskis, Kārlis, Sanda Jēgere, Inga Narbute, et al.. (2023). Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients. European Heart Journal. 44(Supplement_2). 2 indexed citations
5.
Sondore, Dace, et al.. (2023). Association between carotid and coronary atherosclerotic plaque morphology: a virtual histology intravascular ultrasound study. Journal of Clinical and Translational Research. 9(4). 253–260. 3 indexed citations
6.
Trušinskis, Kārlis, Sanda Jēgere, Indulis Kumsārs, et al.. (2022). What Is Hidden Behind Yellow Pixels: from Pathology to Intravascular Imaging of Atherosclerotic Plaque. Current Atherosclerosis Reports. 24(2). 97–108. 1 indexed citations
7.
Ērglis, Andrejs, Inga Narbute, Dace Sondore, et al.. (2022). Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium. Journal of Interventional Cardiology. 2022. 1–8. 1 indexed citations
8.
Trušinskis, Kārlis, William Crawford, Sanda Jēgere, et al.. (2020). Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics.. PubMed. 5(2). 60–67. 16 indexed citations
9.
Trušinskis, Kārlis, William Crawford, Sanda Jēgere, et al.. (2019). Circulating plasma microRNA-126, -145 and -155 and their association with atherosclerotic plaque characteristics. Journal of Clinical and Translational Research. 4 indexed citations
10.
Narbute, Inga, Indulis Kumsārs, Dace Sondore, et al.. (2018). Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data. Advances in Interventional Cardiology. 14(2). 144–148. 2 indexed citations
11.
Verheye, Stefan, Mathias Vrolix, Indulis Kumsārs, et al.. (2017). The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis). JACC: Cardiovascular Interventions. 10(20). 2029–2037. 46 indexed citations
12.
Kumsārs, Indulis, Inga Narbute, Leif Thuesen, et al.. (2012). Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy. EuroIntervention. 7(10). 1155–1161. 43 indexed citations
13.
Narbute, Inga, Sanda Jēgere, Indulis Kumsārs, et al.. (2011). Are Paclitaxel-Eluting Stents Better in Unprotected Left Main Coronary Artery Disease? Three-Year Clinical and Intravascular Imaging Results From a Randomized Study. Medicina. 47(10). 77–77. 5 indexed citations
14.
Fusaro, Massimiliano, Giuseppe Biondi‐Zoccai, Dace Sondore, et al.. (2007). Iatrogenic vessel perforation during below-the-knee percutaneous revascularisation for critical limb ischaemia: successful management with deep catheter intubation and prolonged balloon inflations. Journal of Cardiovascular Medicine. 8(4). 305–308. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026